Ontario’s Publicly Funded Immunization Schedules
The Ministry of Health and Long-Term Care has made changes to the Publicly Funded Immunization Schedules for Ontario (Schedules). The newly revised Schedules replace the January 2009 versions.
Revisions to the Schedules are based on the recommendations from the National Advisory Committee on Immunization (NACI), the Provincial Infectious Diseases Advisory Committee – Immunization (PIDAC-I), and feedback of a review committee comprised of selected public health nurses and associate medical officers of health.
Immunization Schedules – August 2011
You may also order more materials at www.serviceontario.ca/publications
The key changes and/or additions to the Schedules include the following :
Pneumococcal conjugate vaccine (Pneu-C-13)
- Replacement of Prevnar® 7 and Synflorix® vaccines with the Prevnar® 13 vaccine for infants and children less than five years of age for broader protection against invasive pneumococcal disease.
- A reduced dosing schedule for low risk children from a 4-dose to a 3-dose Pneu-C-13 series.
- High risk children will continue to receive a four-dose series with the Pneu-C-13 vaccine.
- Additional high risk eligibility criteria for Pneu-C-13 vaccine for children less than 5 years of age.
- Children starting immunization at one year to less than five years of age are eligible to receive Pneu-C-13 as per Schedule 2 and Tables 2 and 3.
- Both detailed schedules for low risk children (Table 2) and high risk children (Table 3) can be found on page 2 of the Schedules
Rotavirus vaccine (Rot-1)
- Publicly funded rotavirus vaccine, Rotarix™, has been added to the Schedules.
- Infants are eligible to receive the vaccine at two and four months of age, the two doses must be completed by 24 weeks of age.
- The first dose can be administered from the age of 6 weeks. There should be an interval of at least 4 weeks between doses. The administration of the two doses should be completed by the age of 24 weeks.
Varicella vaccine (Var)
- Two doses of varicella vaccine are now recommended for all children up to twelve years old.
- Children born on or after January 1, 2000, who have received two doses of MMR vaccine and one dose of single varicella vaccine, will be offered a second dose of the single varicella vaccine. I.
Measles and mumps second dose eligibility
- A second dose of MMR is recommended for young adults (18-25 years), post secondary students, persons who received killed measles vaccine (1967-1970), health care workers or those who plan to travel internationally.
Measles, mumps and rubella vaccine (MMR)
- MMR vaccine should be administered at 12 months of age and the second dose of MMR should be given as MMRV between four to six years of age (preferably prior to school entry).
Measles, mumps, rubella and varicella vaccine (MMRV)
- Publicly funded MMRV vaccine, Priorix-Tetra™ has been added to the Schedules.
- The second dose of MMR and varicella vaccines should be given as MMRV between four to six years of age (preferably prior to school entry).
Meningococcal conjugate ACYW-135 vaccine (Men-C-ACYW)
- Since September 2009, unimmunized adolescents remain eligible after grade 7 until they are immunized